HR 1524: General Assembly; reschedule marijuana from a Schedule I substance to a Schedule III substance in accordance with presidential Executive Order 14370; urge

This resolution does not change any Georgia law itself. Instead, it expresses the House of Representatives' position that the General Assembly should act to move marijuana from Schedule I to Schedule III under Georgia's drug scheduling system, matching a federal effort already underway through the U.S. Department of Justice and a December 2025 presidential executive order. The resolution cites federal findings, including a 2023 FDA review supporting marijuana's medical use for pain, nausea, and appetite loss, and a Department of Health and Human Services recommendation to reschedule it federally. It notes that about 40 states already have medical marijuana programs. The resolution urges lawmakers to move quickly on rescheduling and to support more research into medical marijuana and cannabidiol, and directs the Speaker of the House to distribute copies of the resolution to the General Assembly.

• Formally urges the Georgia General Assembly to reschedule marijuana from Schedule I to Schedule III of the state's controlled substances classification.
• Calls on lawmakers to take steps to increase research into medical marijuana and cannabidiol to better inform patients and doctors.
• Directs the Speaker of the House to make copies of the resolution available for distribution to the General Assembly.
• Does not itself amend any Georgia statute; it expresses the House's position rather than enacting a binding legal change.

Georgia lawmakers who would need to act on any future rescheduling legislation, patients and doctors involved in medical marijuana treatment, and state agencies that regulate controlled substances. It does not directly change rules for law enforcement, businesses, or individuals unless further legislation follows.

Because this is a resolution rather than a law, it does not change what is legal in Georgia. But it signals House support for reclassifying marijuana, which could pave the way for future legislation affecting medical marijuana access, research funding, and how the drug is treated under state law.

• Recites federal findings from the FDA, HHS, and National Institute on Drug Abuse supporting reclassification of marijuana from Schedule I to Schedule III.
• References the Department of Justice's May 2024 proposed federal rule to reschedule marijuana and a December 18, 2025 presidential executive order directing expedited federal action.
• States that the House of Representatives resolves to urge the General Assembly to reschedule marijuana and pursue increased medical marijuana and cannabidiol research.
• Directs the Speaker of the House to distribute copies of the resolution to the General Assembly.

1. 2026-03-06House Second Readers (Cámara de Representantes)
2. 2026-03-04House First Readers (Cámara de Representantes)
3. 2026-03-03House Hopper (Cámara de Representantes)

• Eric Bell (D, HD-075)Patrocinador principal
• Derrick Jackson (D, HD-068)
• El-Mahdi Holly (D, HD-116)
• Spencer Frye (D, HD-122)
• Samuel Park (D, HD-107)

• marijuana rescheduling
• medical marijuana
• drug policy
• cannabis research